Good Pharma Scorecard

We rank bio-pharmaceutical companies and new drugs on ethics and public health performance criteria, focusing on issues that are critical to patients.

The Good Pharma Scorecard ranks companies and new medicines on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. Subsequent versions of the scorecard will also evaluate the integrity of clinical trial designs, the accessibility of medicines, drug marketing practices, and other ethics and human rights issues.

Clinical Trial Transparency and Data Sharing
Are Important Because:

Transparency is key to protecting and respecting research participants and  users of medicines and vaccines

Evidenced based medicine requires all evidence to be in the public domain

Being able to learn from what other scientists have already done- both accomplishments and failures- stimulates innovation and ultimately the delivery of lifesaving results.

Transparency is key to maximizing the value of generated trial data and people’s participation in trials

Opacity can drive up costs of research and care

Transparency and data-sharing enable validation and replication of study findings

Rankings

View Good Pharma Scorecard rankings by

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Belsomra Merck Sharp & Dohme Insomnia
Merck Sharp & Dohme
Insomnia
# 1 Cerdelga Sanofi / Genzyme Gaucher Disease
Sanofi / Genzyme
Gaucher Disease
# 1 Invokamet Johnson & Johnson / Janssen Type 2 Diabetes
Johnson & Johnson / Janssen
Type 2 Diabetes
# 1 Jublia Valeant / Dow Onychomycosis
Valeant / Dow
Onychomycosis
# 1 Movantik AstraZeneca Constipation
AstraZeneca
Constipation
# 1 Otezla Celgene Arthritis & Psoriasis
Celgene
Arthritis & Psoriasis
# 1 Viekira Pak AbbVie Hepatitis C
AbbVie
Hepatitis C
# 1 Zerbaxa Merck & Co / Cubist Urinary & Abdominal Infections
Merck & Co / Cubist
Urinary & Abdominal Infections
# 1 Zykadia Novartis Lung Cancer
Novartis
Lung Cancer
# 10 Lynparza AstraZeneca Ovarian Cancer
AstraZeneca
Ovarian Cancer
96% Median Median score

Median: 96%

# 11 Farxiga AstraZeneca Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
# 12 Xigduo XR AstraZeneca Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
# 13 Sivextro Merck & Co / Cubist Skin Infection
Merck & Co / Cubist
Skin Infection
# 13 Zontivity Merck Sharp & Dohme Thrombotic Cardiovascular Events
Merck Sharp & Dohme
Thrombotic Cardiovascular Events
# 15 Zydelig Gilead Leukemia
Gilead
Leukemia
# 16 Dalvance Allergan / Durata Skin Infection
Allergan / Durata
Skin Infection
# 17 Harvoni Gilead Hepatitis C
Gilead
Hepatitis C
# 18 Esbriet Roche / Genentech Pulmonary Fibrosis
Roche / Genentech
Pulmonary Fibrosis
# 19 Xtoro Novartis / Alcon Otitis Externa
Novartis / Alcon
Otitis Externa